Adelaide BioMed City: A Cluster for Health and Biomedical Innovation

With more than AUD 3.6 billion invested in infrastructure, Adelaide BioMed City is one of the largest biomedical clusters in the Southern Hemisphere, bringing together world-class research, education, clinical care, and industry collaboration.

The precinct co-locates key institutions, including the Royal Adelaide Hospital, the South Australian Health and Medical Research Institute (SAHMRI)Dealroom has a profile for this one. Try Dealroom →, and facilities from the University of AdelaideDealroom has a profile for this one. Try Dealroom →, University of South AustraliaDealroom has a profile for this one. Try Dealroom →, and Flinders UniversityDealroom has a profile for this one. Try Dealroom →.

It is also home to the Centre for Cancer BiologyDealroom has a profile for this one. Try Dealroom → and will include the Australian Bragg Centre for Proton Therapy and ResearchDealroom has a profile for this one. Try Dealroom →, which will house Australia’s first proton therapy unit.

Adelaide BioMed City fosters collaboration between researchers, clinicians, students, and industry partners, supporting the full lifecycle of medical research from discovery to clinical application and commercialisation.

This integrated approach aims to accelerate health innovation, improve patient outcomes, and attract investment to South Australia’s health sector.

J.V.